TW239077B - - Google Patents

Info

Publication number
TW239077B
TW239077B TW082109174A TW82109174A TW239077B TW 239077 B TW239077 B TW 239077B TW 082109174 A TW082109174 A TW 082109174A TW 82109174 A TW82109174 A TW 82109174A TW 239077 B TW239077 B TW 239077B
Authority
TW
Taiwan
Application number
TW082109174A
Other languages
Chinese (zh)
Original Assignee
Procyte Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procyte Corp filed Critical Procyte Corp
Application granted granted Critical
Publication of TW239077B publication Critical patent/TW239077B/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/555Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
TW082109174A 1993-06-02 1993-11-03 TW239077B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7144093A 1993-06-02 1993-06-02

Publications (1)

Publication Number Publication Date
TW239077B true TW239077B (en) 1995-01-21

Family

ID=22101339

Family Applications (1)

Application Number Title Priority Date Filing Date
TW082109174A TW239077B (en) 1993-06-02 1993-11-03

Country Status (8)

Country Link
EP (1) EP0701439A1 (en)
JP (1) JPH08511006A (en)
AU (1) AU7051794A (en)
CA (1) CA2163640A1 (en)
OA (1) OA10198A (en)
TW (1) TW239077B (en)
WO (1) WO1994027594A2 (en)
ZA (1) ZA943857B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6562854B2 (en) 1994-12-14 2003-05-13 Axys Pharmaceuticals, Inc. Compositions comprising a substituted benzimidazole useful for treating immunomediated inflammatory disorders
AU6274896A (en) * 1995-06-06 1996-12-24 Procyte Corporation Stable copper(i) complexes as active therapeutic substances
US5637311A (en) * 1995-06-29 1997-06-10 Procyte Corporation Zinc(II) complexes and methods related thereto
US7045531B1 (en) 1997-03-11 2006-05-16 The General Hospital Corporation Composition comprising a metal chelator and a method of treating amyloidosis by administering the metal chelator
US6150379A (en) * 1997-11-26 2000-11-21 Axys Pharmaceuticals, Inc. Compounds and compositions as anticoagulants
US6638711B1 (en) 1999-04-29 2003-10-28 The General Hospital Corporation Methods for identifying an agent that inhibits oxygen-dependent hydrogen peroxide formation activity but does not inhibit superoxide-dependent hydrogen peroxide formation
CA2568134A1 (en) * 2004-05-24 2005-12-08 New York University Method of treating or preventing pathologic effects of acute increases in hyperglycemia and/or acute increases of free fatty acid flux
ES2396719T3 (en) 2005-06-20 2013-02-25 Dynamiclear Pty Ltd Composition for treatment of skin lesions
AU2009287980B2 (en) * 2008-09-03 2014-05-22 Nbc Meshtec, Inc. Anti-viral agent
US10098857B2 (en) 2008-10-10 2018-10-16 The Board Of Trustees Of The Leland Stanford Junior University Topical and transdermal delivery of HIF-1 modulators to prevent and treat chronic wounds
TWI580787B (en) * 2012-12-28 2017-05-01 簡宏堅 Recombinant protein, pharmaceutical composition containing the same, and method of biosynthesizing thereof
US11331288B2 (en) 2017-09-14 2022-05-17 The Board Of Trustees Of The Leland Stanford Junior University Conditioning irradiated tissue for increasing vascularity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4760051A (en) * 1985-01-24 1988-07-26 Pickart Loren R Use of GHL-Cu as a wound-healing and anti-inflammatory agent
JPS6259213A (en) * 1985-09-10 1987-03-14 Eisai Co Ltd Superoxide remover

Also Published As

Publication number Publication date
EP0701439A1 (en) 1996-03-20
JPH08511006A (en) 1996-11-19
WO1994027594A3 (en) 1995-04-27
ZA943857B (en) 1995-02-01
WO1994027594A2 (en) 1994-12-08
AU7051794A (en) 1994-12-20
CA2163640A1 (en) 1994-12-08
OA10198A (en) 1996-12-18

Similar Documents

Publication Publication Date Title
ATA195993A (en)
DE9304933U1 (en)
TW239077B (en)
DE9304603U1 (en)
DE9305309U1 (en)
DE9303862U1 (en)
DE9302897U1 (en)
DE9302888U1 (en)
DE9304892U1 (en)
DE9306552U1 (en)
DE9301203U1 (en)
DE9301978U1 (en)
DE9301890U1 (en)
DE9302548U1 (en)
DE9301751U1 (en)
DE9302521U1 (en)
DE9301425U1 (en)
DE9306665U1 (en)
DE9304911U1 (en)
DE9301770U1 (en)
DE9300900U1 (en)
DE9305025U1 (en)
DE9306786U1 (en)
DE9304438U1 (en)
DE9305613U1 (en)